Molecular Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向：肿瘤;血管新生 经验分享：投稿三天，一直是editor appointed, 这个状态会持续多久呢，下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：求问已投稿的各位仁兄，editor appointed这个状态多久之后编辑会做出下一步决定呢？目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107030, encodeId=9442210e03044, content=偏重的研究方向：肿瘤 经验分享：各位前辈，近期向molecular cancer 投了一篇综述，一审2个月后给了major revision，修回后二审1个月现在状态显示为“Reviewer reports received / Ready for editor’s decision”，已经3天了没有任何变化，一般这种状态多长时间会有结果？不会是因为快过圣诞节了，编辑都休假了导致延迟吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a80877658, createdName=wooshiwo, createdTime=Thu Dec 22 09:54:37 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2164991, encodeId=137d2164991bb, content=终于接收啦历经四个月。希望杂志越来越好吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Thu Oct 26 10:02:22 CST 2023, time=2023-10-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151627, encodeId=7faf215162e16, content=审稿速度:2.0 偏重的研究方向：circRNA;肿瘤 经验分享：7月20号送审的，今天还没有变化，有没有同样情况的小伙伴。什么时候可以修回呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Mon Aug 07 16:05:21 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186865, encodeId=0d181186865d7, content=editor invited三个月，这杂志是怎么了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Fri Jan 21 16:20:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163852, encodeId=929f216385290, content=很难投中，绝不是传说中的可以拿来灌水的水平，没有扎实的工作量基本上秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0eb8776124, createdName=ms1000001749825166, createdTime=Fri Oct 20 00:25:46 CST 2023, time=2023-10-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161782, encodeId=e65d2161e8249, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:39:18 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161783, encodeId=52962161e8316, content=偏重的研究方向：circRNA;肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:41:48 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省)]

2022-05-18 14672ee2m82暂无昵称

老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗

99 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向：肿瘤;血管新生 经验分享：投稿三天，一直是editor appointed, 这个状态会持续多久呢，下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：求问已投稿的各位仁兄，editor appointed这个状态多久之后编辑会做出下一步决定呢？目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107030, encodeId=9442210e03044, content=偏重的研究方向：肿瘤 经验分享：各位前辈，近期向molecular cancer 投了一篇综述，一审2个月后给了major revision，修回后二审1个月现在状态显示为“Reviewer reports received / Ready for editor’s decision”，已经3天了没有任何变化，一般这种状态多长时间会有结果？不会是因为快过圣诞节了，编辑都休假了导致延迟吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a80877658, createdName=wooshiwo, createdTime=Thu Dec 22 09:54:37 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2164991, encodeId=137d2164991bb, content=终于接收啦历经四个月。希望杂志越来越好吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Thu Oct 26 10:02:22 CST 2023, time=2023-10-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151627, encodeId=7faf215162e16, content=审稿速度:2.0 偏重的研究方向：circRNA;肿瘤 经验分享：7月20号送审的，今天还没有变化，有没有同样情况的小伙伴。什么时候可以修回呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Mon Aug 07 16:05:21 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186865, encodeId=0d181186865d7, content=editor invited三个月，这杂志是怎么了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Fri Jan 21 16:20:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163852, encodeId=929f216385290, content=很难投中，绝不是传说中的可以拿来灌水的水平，没有扎实的工作量基本上秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0eb8776124, createdName=ms1000001749825166, createdTime=Fri Oct 20 00:25:46 CST 2023, time=2023-10-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161782, encodeId=e65d2161e8249, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:39:18 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161783, encodeId=52962161e8316, content=偏重的研究方向：circRNA;肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:41:48 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省)]

2022-09-21 14856b50m82暂无昵称

偏重的研究方向：肿瘤;血管新生
经验分享：投稿三天，一直是editor appointed, 这个状态会持续多久呢，下一步会是什么🤔

172 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向：肿瘤;血管新生 经验分享：投稿三天，一直是editor appointed, 这个状态会持续多久呢，下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：求问已投稿的各位仁兄，editor appointed这个状态多久之后编辑会做出下一步决定呢？目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107030, encodeId=9442210e03044, content=偏重的研究方向：肿瘤 经验分享：各位前辈，近期向molecular cancer 投了一篇综述，一审2个月后给了major revision，修回后二审1个月现在状态显示为“Reviewer reports received / Ready for editor’s decision”，已经3天了没有任何变化，一般这种状态多长时间会有结果？不会是因为快过圣诞节了，编辑都休假了导致延迟吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a80877658, createdName=wooshiwo, createdTime=Thu Dec 22 09:54:37 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2164991, encodeId=137d2164991bb, content=终于接收啦历经四个月。希望杂志越来越好吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Thu Oct 26 10:02:22 CST 2023, time=2023-10-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151627, encodeId=7faf215162e16, content=审稿速度:2.0 偏重的研究方向：circRNA;肿瘤 经验分享：7月20号送审的，今天还没有变化，有没有同样情况的小伙伴。什么时候可以修回呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Mon Aug 07 16:05:21 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186865, encodeId=0d181186865d7, content=editor invited三个月，这杂志是怎么了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Fri Jan 21 16:20:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163852, encodeId=929f216385290, content=很难投中，绝不是传说中的可以拿来灌水的水平，没有扎实的工作量基本上秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0eb8776124, createdName=ms1000001749825166, createdTime=Fri Oct 20 00:25:46 CST 2023, time=2023-10-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161782, encodeId=e65d2161e8249, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:39:18 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161783, encodeId=52962161e8316, content=偏重的研究方向：circRNA;肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:41:48 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省)]

2023-08-12 ms7000000365645384 来自北京

审稿速度:6.0
偏重的研究方向：肿瘤
经验分享：求问已投稿的各位仁兄，editor appointed这个状态多久之后编辑会做出下一步决定呢？目前已4天

67 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向：肿瘤;血管新生 经验分享：投稿三天，一直是editor appointed, 这个状态会持续多久呢，下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：求问已投稿的各位仁兄，editor appointed这个状态多久之后编辑会做出下一步决定呢？目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107030, encodeId=9442210e03044, content=偏重的研究方向：肿瘤 经验分享：各位前辈，近期向molecular cancer 投了一篇综述，一审2个月后给了major revision，修回后二审1个月现在状态显示为“Reviewer reports received / Ready for editor’s decision”，已经3天了没有任何变化，一般这种状态多长时间会有结果？不会是因为快过圣诞节了，编辑都休假了导致延迟吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a80877658, createdName=wooshiwo, createdTime=Thu Dec 22 09:54:37 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2164991, encodeId=137d2164991bb, content=终于接收啦历经四个月。希望杂志越来越好吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Thu Oct 26 10:02:22 CST 2023, time=2023-10-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151627, encodeId=7faf215162e16, content=审稿速度:2.0 偏重的研究方向：circRNA;肿瘤 经验分享：7月20号送审的，今天还没有变化，有没有同样情况的小伙伴。什么时候可以修回呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Mon Aug 07 16:05:21 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186865, encodeId=0d181186865d7, content=editor invited三个月，这杂志是怎么了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Fri Jan 21 16:20:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163852, encodeId=929f216385290, content=很难投中，绝不是传说中的可以拿来灌水的水平，没有扎实的工作量基本上秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0eb8776124, createdName=ms1000001749825166, createdTime=Fri Oct 20 00:25:46 CST 2023, time=2023-10-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161782, encodeId=e65d2161e8249, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:39:18 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161783, encodeId=52962161e8316, content=偏重的研究方向：circRNA;肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:41:48 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省)]

2022-12-22 wooshiwo 来自辽宁省

偏重的研究方向：肿瘤
经验分享：各位前辈，近期向molecular cancer 投了一篇综述，一审2个月后给了major revision，修回后二审1个月现在状态显示为“Reviewer reports received / Ready for editor’s decision”，已经3天了没有任何变化，一般这种状态多长时间会有结果？不会是因为快过圣诞节了，编辑都休假了导致延迟吧？

70 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向：肿瘤;血管新生 经验分享：投稿三天，一直是editor appointed, 这个状态会持续多久呢，下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：求问已投稿的各位仁兄，editor appointed这个状态多久之后编辑会做出下一步决定呢？目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107030, encodeId=9442210e03044, content=偏重的研究方向：肿瘤 经验分享：各位前辈，近期向molecular cancer 投了一篇综述，一审2个月后给了major revision，修回后二审1个月现在状态显示为“Reviewer reports received / Ready for editor’s decision”，已经3天了没有任何变化，一般这种状态多长时间会有结果？不会是因为快过圣诞节了，编辑都休假了导致延迟吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a80877658, createdName=wooshiwo, createdTime=Thu Dec 22 09:54:37 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2164991, encodeId=137d2164991bb, content=终于接收啦历经四个月。希望杂志越来越好吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Thu Oct 26 10:02:22 CST 2023, time=2023-10-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151627, encodeId=7faf215162e16, content=审稿速度:2.0 偏重的研究方向：circRNA;肿瘤 经验分享：7月20号送审的，今天还没有变化，有没有同样情况的小伙伴。什么时候可以修回呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Mon Aug 07 16:05:21 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186865, encodeId=0d181186865d7, content=editor invited三个月，这杂志是怎么了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Fri Jan 21 16:20:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163852, encodeId=929f216385290, content=很难投中，绝不是传说中的可以拿来灌水的水平，没有扎实的工作量基本上秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0eb8776124, createdName=ms1000001749825166, createdTime=Fri Oct 20 00:25:46 CST 2023, time=2023-10-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161782, encodeId=e65d2161e8249, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:39:18 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161783, encodeId=52962161e8316, content=偏重的研究方向：circRNA;肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:41:48 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省)]

2023-10-26 ms4000001583479348 来自北京

终于接收啦历经四个月。希望杂志越来越好吧。

33 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向：肿瘤;血管新生 经验分享：投稿三天，一直是editor appointed, 这个状态会持续多久呢，下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：求问已投稿的各位仁兄，editor appointed这个状态多久之后编辑会做出下一步决定呢？目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107030, encodeId=9442210e03044, content=偏重的研究方向：肿瘤 经验分享：各位前辈，近期向molecular cancer 投了一篇综述，一审2个月后给了major revision，修回后二审1个月现在状态显示为“Reviewer reports received / Ready for editor’s decision”，已经3天了没有任何变化，一般这种状态多长时间会有结果？不会是因为快过圣诞节了，编辑都休假了导致延迟吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a80877658, createdName=wooshiwo, createdTime=Thu Dec 22 09:54:37 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2164991, encodeId=137d2164991bb, content=终于接收啦历经四个月。希望杂志越来越好吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Thu Oct 26 10:02:22 CST 2023, time=2023-10-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151627, encodeId=7faf215162e16, content=审稿速度:2.0 偏重的研究方向：circRNA;肿瘤 经验分享：7月20号送审的，今天还没有变化，有没有同样情况的小伙伴。什么时候可以修回呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Mon Aug 07 16:05:21 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186865, encodeId=0d181186865d7, content=editor invited三个月，这杂志是怎么了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Fri Jan 21 16:20:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163852, encodeId=929f216385290, content=很难投中，绝不是传说中的可以拿来灌水的水平，没有扎实的工作量基本上秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0eb8776124, createdName=ms1000001749825166, createdTime=Fri Oct 20 00:25:46 CST 2023, time=2023-10-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161782, encodeId=e65d2161e8249, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:39:18 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161783, encodeId=52962161e8316, content=偏重的研究方向：circRNA;肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:41:48 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省)]

2023-08-07 ms4000001583479348 来自北京

审稿速度:2.0
偏重的研究方向：circRNA;肿瘤
经验分享：7月20号送审的，今天还没有变化，有没有同样情况的小伙伴。什么时候可以修回呀

57 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向：肿瘤;血管新生 经验分享：投稿三天，一直是editor appointed, 这个状态会持续多久呢，下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：求问已投稿的各位仁兄，editor appointed这个状态多久之后编辑会做出下一步决定呢？目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107030, encodeId=9442210e03044, content=偏重的研究方向：肿瘤 经验分享：各位前辈，近期向molecular cancer 投了一篇综述，一审2个月后给了major revision，修回后二审1个月现在状态显示为“Reviewer reports received / Ready for editor’s decision”，已经3天了没有任何变化，一般这种状态多长时间会有结果？不会是因为快过圣诞节了，编辑都休假了导致延迟吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a80877658, createdName=wooshiwo, createdTime=Thu Dec 22 09:54:37 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2164991, encodeId=137d2164991bb, content=终于接收啦历经四个月。希望杂志越来越好吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Thu Oct 26 10:02:22 CST 2023, time=2023-10-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151627, encodeId=7faf215162e16, content=审稿速度:2.0 偏重的研究方向：circRNA;肿瘤 经验分享：7月20号送审的，今天还没有变化，有没有同样情况的小伙伴。什么时候可以修回呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Mon Aug 07 16:05:21 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186865, encodeId=0d181186865d7, content=editor invited三个月，这杂志是怎么了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Fri Jan 21 16:20:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163852, encodeId=929f216385290, content=很难投中，绝不是传说中的可以拿来灌水的水平，没有扎实的工作量基本上秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0eb8776124, createdName=ms1000001749825166, createdTime=Fri Oct 20 00:25:46 CST 2023, time=2023-10-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161782, encodeId=e65d2161e8249, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:39:18 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161783, encodeId=52962161e8316, content=偏重的研究方向：circRNA;肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:41:48 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省)]

2022-01-21 summereason

editor invited三个月，这杂志是怎么了？？？

245 27

展开27条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向：肿瘤;血管新生 经验分享：投稿三天，一直是editor appointed, 这个状态会持续多久呢，下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：求问已投稿的各位仁兄，editor appointed这个状态多久之后编辑会做出下一步决定呢？目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107030, encodeId=9442210e03044, content=偏重的研究方向：肿瘤 经验分享：各位前辈，近期向molecular cancer 投了一篇综述，一审2个月后给了major revision，修回后二审1个月现在状态显示为“Reviewer reports received / Ready for editor’s decision”，已经3天了没有任何变化，一般这种状态多长时间会有结果？不会是因为快过圣诞节了，编辑都休假了导致延迟吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a80877658, createdName=wooshiwo, createdTime=Thu Dec 22 09:54:37 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2164991, encodeId=137d2164991bb, content=终于接收啦历经四个月。希望杂志越来越好吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Thu Oct 26 10:02:22 CST 2023, time=2023-10-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151627, encodeId=7faf215162e16, content=审稿速度:2.0 偏重的研究方向：circRNA;肿瘤 经验分享：7月20号送审的，今天还没有变化，有没有同样情况的小伙伴。什么时候可以修回呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Mon Aug 07 16:05:21 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186865, encodeId=0d181186865d7, content=editor invited三个月，这杂志是怎么了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Fri Jan 21 16:20:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163852, encodeId=929f216385290, content=很难投中，绝不是传说中的可以拿来灌水的水平，没有扎实的工作量基本上秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0eb8776124, createdName=ms1000001749825166, createdTime=Fri Oct 20 00:25:46 CST 2023, time=2023-10-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161782, encodeId=e65d2161e8249, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:39:18 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161783, encodeId=52962161e8316, content=偏重的研究方向：circRNA;肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:41:48 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省)]

2023-10-20 ms1000001749825166 来自江苏省

很难投中，绝不是传说中的可以拿来灌水的水平，没有扎实的工作量基本上秒拒。

44 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向：肿瘤;血管新生 经验分享：投稿三天，一直是editor appointed, 这个状态会持续多久呢，下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：求问已投稿的各位仁兄，editor appointed这个状态多久之后编辑会做出下一步决定呢？目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107030, encodeId=9442210e03044, content=偏重的研究方向：肿瘤 经验分享：各位前辈，近期向molecular cancer 投了一篇综述，一审2个月后给了major revision，修回后二审1个月现在状态显示为“Reviewer reports received / Ready for editor’s decision”，已经3天了没有任何变化，一般这种状态多长时间会有结果？不会是因为快过圣诞节了，编辑都休假了导致延迟吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a80877658, createdName=wooshiwo, createdTime=Thu Dec 22 09:54:37 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2164991, encodeId=137d2164991bb, content=终于接收啦历经四个月。希望杂志越来越好吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Thu Oct 26 10:02:22 CST 2023, time=2023-10-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151627, encodeId=7faf215162e16, content=审稿速度:2.0 偏重的研究方向：circRNA;肿瘤 经验分享：7月20号送审的，今天还没有变化，有没有同样情况的小伙伴。什么时候可以修回呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Mon Aug 07 16:05:21 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186865, encodeId=0d181186865d7, content=editor invited三个月，这杂志是怎么了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Fri Jan 21 16:20:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163852, encodeId=929f216385290, content=很难投中，绝不是传说中的可以拿来灌水的水平，没有扎实的工作量基本上秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0eb8776124, createdName=ms1000001749825166, createdTime=Fri Oct 20 00:25:46 CST 2023, time=2023-10-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161782, encodeId=e65d2161e8249, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:39:18 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161783, encodeId=52962161e8316, content=偏重的研究方向：circRNA;肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:41:48 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省)]

2023-10-09 summereason 来自江苏省

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤;表观遗传
经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1220577, encodeId=a4b012205e781, content=老师前辈们1 reviewer report received 三个多月了一直没动静可以催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30135139626, createdName=14672ee2m82暂无昵称, createdTime=Wed May 18 00:01:28 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089546, encodeId=46a6208954658, content=偏重的研究方向：肿瘤;血管新生 经验分享：投稿三天，一直是editor appointed, 这个状态会持续多久呢，下一步会是什么🤔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6a5287300, createdName=14856b50m82暂无昵称, createdTime=Wed Sep 21 14:58:39 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152439, encodeId=ac152152439cc, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：求问已投稿的各位仁兄，editor appointed这个状态多久之后编辑会做出下一步决定呢？目前已4天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86405402847, createdName=ms7000000365645384, createdTime=Sat Aug 12 16:37:29 CST 2023, time=2023-08-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2107030, encodeId=9442210e03044, content=偏重的研究方向：肿瘤 经验分享：各位前辈，近期向molecular cancer 投了一篇综述，一审2个月后给了major revision，修回后二审1个月现在状态显示为“Reviewer reports received / Ready for editor’s decision”，已经3天了没有任何变化，一般这种状态多长时间会有结果？不会是因为快过圣诞节了，编辑都休假了导致延迟吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a80877658, createdName=wooshiwo, createdTime=Thu Dec 22 09:54:37 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2164991, encodeId=137d2164991bb, content=终于接收啦历经四个月。希望杂志越来越好吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Thu Oct 26 10:02:22 CST 2023, time=2023-10-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151627, encodeId=7faf215162e16, content=审稿速度:2.0 偏重的研究方向：circRNA;肿瘤 经验分享：7月20号送审的，今天还没有变化，有没有同样情况的小伙伴。什么时候可以修回呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47dd6406460, createdName=ms4000001583479348, createdTime=Mon Aug 07 16:05:21 CST 2023, time=2023-08-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1186865, encodeId=0d181186865d7, content=editor invited三个月，这杂志是怎么了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Fri Jan 21 16:20:23 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163852, encodeId=929f216385290, content=很难投中，绝不是传说中的可以拿来灌水的水平，没有扎实的工作量基本上秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0eb8776124, createdName=ms1000001749825166, createdTime=Fri Oct 20 00:25:46 CST 2023, time=2023-10-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161782, encodeId=e65d2161e8249, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:39:18 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2161783, encodeId=52962161e8316, content=偏重的研究方向：circRNA;肿瘤;表观遗传 经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5612360146, createdName=summereason, createdTime=Mon Oct 09 17:41:48 CST 2023, time=2023-10-09, status=1, ipAttribution=江苏省)]

2023-10-09 summereason 来自江苏省

偏重的研究方向：circRNA;肿瘤;表观遗传
经验分享：关注该期刊的Research系列文章一年了，为编辑部即使发现问题并调整方向感到高兴，目前稿源的研究方向、地区分布比例比之前有较大提升，每期也不乏大量漂亮的科研工作。诚然，依然有些工作看起来逊色于这个IF，总体来说还是稳中向好吧，希望杂志越来越好！

49 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务